Dong Z-C, Zhang D, Zhang X-X, Yao Z-Q, Wu H, Chen C-H, Tian J-Q
Department of Urology, Key Laboratory of Gansu Province for Urological Diseases, Department of Urology of Lanzhou University Second Hospital, Urology institute of Lanzhou University Second Hospital, Lanzhou, Gansu, P.R. China.
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):11990. doi: 10.26355/eurrev_202012_23976.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3β/β-catenin pathway, by Z.-C. Dong, D. Zhang, X.-X. Zhang, Z.-Q. Yao, H. Wu, C.-H. Chen, J.-Q. Tian, published in Eur Rev Med Pharmacol Sci 2019; 23 (13): 5682-5690-DOI: 10.26355/eurrev_201907_18305-PMID: 31298320" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18305.
由于本文被怀疑存在研究不当行为,且通讯作者未回应我们要求证明数据和图表原创性的请求,“Z.-C. 董、D. 张、X.-X. 张、Z.-Q. 姚、H. 吴、C.-H. 陈、J.-Q. 田发表于《欧洲医学与药理学评论》2019年;23(13): 5682 - 5690 - DOI: 10.26355/eurrev_201907_18305 - PMID: 31298320的‘MiR - 155通过调节GSK - 3β/β - 连环蛋白通路影响膀胱癌细胞的增殖和凋亡’”已被撤回。出版方对由此可能造成的不便表示歉意。https://www.europeanreview.org/article/18305